Welcome to our dedicated page for Jack Nathan Med news (Ticker: JNHMF), a resource for investors and traders seeking the latest updates and insights on Jack Nathan Med stock.
Jack Nathan Medical Corp (JNHMF) is a leading healthcare provider offering innovative medical services and solutions. Specializing in retail medical clinics, JNHMF focuses on providing accessible and convenient healthcare to patients across various locations. With a commitment to quality care and patient satisfaction, JNHMF continues to expand its reach and enhance its services through strategic partnerships and cutting-edge technologies.
Jack Nathan Health reported a 24% growth in revenue for the fiscal year 2024, reaching $19.1 million. The company expanded to 245 locations globally, with a focus on Canada and Mexico. The partnership with Walmart drove robust financial outcomes, leading to an increase in revenue. The company opened 9 new clinics in Canada and experienced significant growth in Mexico. Operating expenses decreased, resulting in a smaller net loss compared to the previous year. The balance sheet showed an increase in cash and total assets, with total liabilities also increasing. The company had 87,099,159 common shares outstanding as of January 31, 2024.
Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") announced that all matters voted at the annual general meeting on December 23, 2022, were approved by shareholders. All nominees for the board of directors were elected with strong support, receiving over 97% approval. Key resolutions included the reappointment of MNP LLP as auditors and amendments to the Omnibus Equity Incentive Plan, allowing grants of restricted stock units to executives. The company operates extensive healthcare networks in Canada and Mexico, enhancing patient access through clinics in Walmart locations.